| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.3 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |